Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure

NCT05261321 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT05261321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05261321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure
Lead sponsor
University of British Columbia
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 15, 2022
Completion date
March 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy